Sign In
Buy VNDA
$6.09
-0.0400 (-0.653%)
At Close: Jun 03, 2026
Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
04:01pm, Wednesday, 08'th May 2024
Revenues for Q1 2024 were $47.5 million, an increase of 5% compared to Q4 2023 Cash increase of $5.9 million in Q1 2024 to $394.1 million Fanapt® approved for the acute treatment of bipolar I disorde
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
11:16am, Tuesday, 07'th May 2024
No Shareholder Action Required at This Time WASHINGTON , May 7, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it has received a revised
Future Pak Increases Bid for Vanda Pharmaceuticals to Include CVRs in Addition to $7.25 to $7.75 Per Share in Cash
09:00am, Tuesday, 07'th May 2024
WIXOM, Mich.--(BUSINESS WIRE)--Future Pak LLC (“Future Pak”) confirms it increased its offer for all outstanding shares of common stock of Vanda Pharmaceuticals (“Vanda” or “the Company”)
Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
04:30pm, Tuesday, 30'th Apr 2024
Conference Call and Webcast to Follow WASHINGTON , April 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2024 o
Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
09:02am, Thursday, 25'th Apr 2024
Investment firm Shareholder Capital sent a letter to drugmaker Vanda Pharmaceuticals' board on Thursday asking it to reconsider Future Pak's takeover offer.
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
07:13pm, Monday, 22'nd Apr 2024
WASHINGTON , April 22, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Supreme Court denied Vanda's petition for a writ of certiorari in its HETLIOZ® A
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
10:09am, Monday, 22'nd Apr 2024
The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents for its sleep-disorder drug Hetlioz that were previously declared invalid in a dispute with generic d
Butler Hall Capital urges Vanda to engage in sales discussions
01:12pm, Friday, 19'th Apr 2024
Hedge fund manager Butler Hall Capital said on Friday it is urging Vanda Pharmaceuticals to form an independent special committee to engage with Future Pak over its takeover offer and run a full sales
Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up
10:46am, Thursday, 18'th Apr 2024
Vanda's (VNDA) board of directors unanimously rejects takeover proposals from Future Pak to acquire all outstanding shares of Vanda. Shares rise on the news.
Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know
10:05am, Thursday, 18'th Apr 2024
Zacks.com users have recently been watching Vanda (VNDA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today
11:53am, Wednesday, 17'th Apr 2024
Vanda confirmed it received several unsolicited acquisition offers from Future Pak. The company's board rejected these proposals, stating that Vanda is worth more than the offered price.
Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
10:21am, Wednesday, 17'th Apr 2024
WASHINGTON , April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today announced that its Board of Directors (the "Board") has adopted a limited duratio
Vanda Pharmaceuticals rejects takeover proposal from Future Pak
09:44am, Wednesday, 17'th Apr 2024
Vanda Pharmaceuticals Inc on Wednesday said it is rejecting a takeover proposal from Future Pak, a privately-held contract manufacturer and packager of pharmaceuticals, as it significantly undervalues
Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
09:02am, Wednesday, 17'th Apr 2024
Board Determined Unsolicited Takeover Proposals Significantly Undervalue the Company No Shareholder Action Required at This Time WASHINGTON , April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc.
Why Is Vanda Pharmaceuticals (VNDA) Stock Up 34% Today?
08:32am, Wednesday, 17'th Apr 2024
Vanda Pharmaceuticals (NASDAQ: VNDA ) stock is rising higher on Wednesday after the biopharmaceutical company received a firm acquisition proposal from Future Pak LLC. Vanda Pharmaceuticals has recei
